Abstract
Intravenous immunoglobulin (IVIg) has been used as an immunomodulatory therapy for the treatment of multiple sclerosis (MS). In the current review, we summarize the up-to-date data related to IVIg clinical trials in MS, and the suggested mechanisms of action by which IVIg modulates the relevant immunological pathways impaired in MS.
Similar content being viewed by others
References
Keegan, B. M., and Noseworthy, J. H. (2002), Annu Rev Med 53, 285–302.
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B. G. (2000), N Engl J Med 343, 938–952.
Fazekas, F., Deisenhammer, F., Strasser-Fuchs, S., Nahler, G., and Mamoli, B. (1997), Lancet 349, 589–593.
Achiron, A., Gabbay, U., Gilad, R., et al. (1998), Neurology 50, 398–402.
Sorensen, P. S., Wanscher, B., Jensen, C. V., et al. (1998), Neurology 50, 1273–1281.
Achiron, A., Kishner, I., Sarova-Pinhas, I., et al. (2004), Arch Neurol 61, 1515–1520.
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., and Moreau, T. (1998), N Engl J Med 339, 285–291.
Achiron, A., Rotstein, Z., Noy, S., Mashiach, S., Dulitzky, M., and Achiron, R. (1996), J Neurol 243, 25–28.
Haas, J. (2000), Mult Scler 6 Suppl 2, S18-S20.
Achiron, A., Kishner, I., Dolev, M., et al. (2004), J Neurol 251, 1133–1137.
Hommes, O. R., Sorensen, P. S., Fazekas, F., et al. (2004), Lancet 364, 1149–1156.
Sorensen, P. S., Haas, J., Sellebjerg, F., Olsson, T., and Ravnborg, M. (2004), Neurology 63, 2028–2033.
Visser, L. H., Beekman, R., Tijssen, C. C., et al. (2004), Mult Scler 10, 89–91.
Kalanie, H., Gharagozli, K., Hemmatie, A., Ghorbanie, M., and Kalanie, A. R. (2004), Eur Neurol 52, 202–206.
Zweiman, B. (1989), Clin Immunol Immunopathol 53, S83-S91.
Berger, T., Rubner, P., Schautzer, F., et al. (2003), N Engl J Med 349, 139–145.
Engelhardt, W., Matzke, J., and Schmidt, R. E. (1995), Immunobiology 192, 297–320.
Sandor, M. and Lynch, R. G. (1993), Immunol Today 14, 227–231.
Jensen, W. A., Marschner, S., Ott, V. L., and Cambier, J. C. (2001), Biochem Soc Trans 29, 840–846.
Ulvestad, E., Williams, K., Vedeler, C., et al. (1994), J Neurol Sci 121, 125–131.
Sospedra, M. and Martin, R. (2005), Annu Rev Immunol 23, 683–747.
Blasczyk, R., Westhoff, U., and Grosse-Wilde, H. (1993), Lancet 341, 789–790.
Hurez, V., Kaveri, S. V., Mouhoub, A., et al. (1994), Ther Immunol 1, 269–277.
Sewell, W. A. and Jolles, S. (2002), Immunology 107, 387–393.
Sooryanarayana, Prasad, N., Bonnin, E., et al. (1999), Biochem Biophys Res Commun 264, 896–901.
Larroche, C., Chanseaud, Y., Garcia de la Pena-Lefebvre, P., and Mouthon, L. (2002), BioDrugs 16, 47–55.
Toyoda, M., Zhang, X., Petrosian, A., Galera, O. A., Wang, S. J., and Jordan, S. C. (1994), J Clin Immunol 14, 178–189.
Abe, Y., Horiuchi, A., Miyake, M., and Kimura, S. (1994), Immunol Rev 139, 5–19.
Andersson, U., Bjork, L., Skansen-Saphir, U., and Andersson, J. (1994), Immunol Rev 139, 21–42.
Achiron, A., Margalit, R., Hershkoviz, R., et al. (1994), J Clin Invest 93, 600–605.
Ross, C., Svenson, M., Nielsen, H., Lundsgaard, C., Hansen, M. B., and Bendtzen, K. (1997), Blood 90, 2376–2380.
Frenette, P. S. and Wagner, D. D. (1996), N Engl J Med 335, 43–45.
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., and Karin, N. (1992), Nature 356, 63–66.
Rigal, D., Vermot-Desroches, C., Heitz, S., Bernaud, J., Alfonsi, F., and Monier, J. C. (1994), Clin Immunol Immunopathol 71, 309–314.
Lapointe, B. M., Herx, L. M., Gill, V., Metz, L. M., and Kubes, P. (2004), Brain 127, 2649–2656.
Gill, V., Doig, C., Knight, D., Love, E., and Kubes, P. (2005), Circulation 112, 2031–2039.
Ronda, N., Haury, M., Nobrega, A., Kaveri, S. V., Coutinho, A., and Kazatchkine, M. D. (1994), Int Immunol 6, 1651.
Olsson, T., Baig, S., Hojeberg, B., and Link, H. (1990), Ann Neurol 27, 132.
Rossi, F. and Kazatchkine, M. D. (1989), J Immunol 143, 4104–4109.
Rodriguez, M., Miller, D. J., and Lennon, V. A. (1996), Neurology 46, 538–545.
Bieber, A., Asakura, K., Warrington, A., Kaveri, S. V., and Rodriguez, M. (2000), Mult Scler 6 Suppl 2, S1-S5.
Asakura, K., Miller, D. J., Murray, K., Bansal, R., Pfeiffer, S. E., and Rodriguez, M. (1996), J Neurosci Res 43, 273–281.
Stangel, M. and Gold, R. (2005), Int MS J 12, 4.
Wurster, U. and Haas, J. (1994), J Neurol Neurosurg Psychiatry 57 Suppl, 21–25.
Nyland, H. and Nilsen, R. (1982), Acta Pathol Microbiol Immunol Scand [C] 90, 217–221.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassman, H. (2002), Ann Neurol 47, 707–714.
Sellebjerg, F., Jaliashvili, I., Christiansen, M., and Garred, P. (1998), J Neurol Sci 157, 168–174.
Mead, R. J., Singhrao, S. K., Neal, J. W., Lassmann, H., and Morgan, B. P. (2002), J Immunol 168, 458–465.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Achiron, A., Miron, S. Intravenous immunoglobulin and multiple sclerosis. Clinic Rev Allerg Immunol 29, 247–254 (2005). https://doi.org/10.1385/CRIAI:29:3:247
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:29:3:247